TELA Bio (TELA) Assets Average (2018 - 2026)

TELA Bio's Assets Average history runs 9 years deep, the most recent figure standing at $75.7 million for Q1 2026.

• On a quarterly basis, Assets Average fell 7.64% year-over-year to $75.7 million in Q1 2026; TTM through Mar 2026 was $75.7 million, a 7.64% decrease from a year earlier, with the FY2025 full-year figure at $84.0 million, up 2.05% from the prior year.
• Assets Average rose to $75.7 million in Q1 2026 per TELA's latest filing, from $71.5 million in the prior quarter.
• Across five years, Assets Average topped out at $90.9 million in Q3 2023 and bottomed at $53.3 million in Q2 2022.
• The 5-year median for Assets Average is $71.5 million (2025), against an average of $70.5 million.
• Across the five-year window, Assets Average soared 43.57% in 2023 and slumped 37.69% in 2024, its largest moves.
• Year by year, Assets Average stood at $73.7 million in 2022, then gained by 12.17% to $82.7 million in 2023, then decreased by 15.59% to $69.8 million in 2024, then advanced by 2.45% to $71.5 million in 2025, then advanced by 5.81% to $75.7 million in 2026.
• Per Business Quant, the three latest TELA Assets Average figures stand at $75.7 million (Q1 2026), $71.5 million (Q4 2025), and $64.6 million (Q3 2025).